Posted by Michael Wonder on 30 Jun 2021
Eli Lilly CEO says drug maker will keep looking for ways to cut insulin costs as Walmart debuts lower price rival
29 June 2021 - Insulin has become a focal point in lawmakers’ debate over soaring drug prices — especially since it is lifesaving for millions of Americans with diabetes.
Eli Lilly CEO David Ricks said he welcomes new competition from Walmart, even as the retailer undercuts the drugmaker’s prices on fast-acting insulin.
